Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
The aMAP risk score is associated with increased mortality in patients with alcohol-related liver disease.
Gut microbiota imbalances, including harmful bacteria like Fusobacterium nucleatum, can promote colorectal cancer through inflammation, DNA damage, and immune disruption, while…
A maximum appendiceal diameter of 10.5 mm or greater helps diagnose complicated appendicitis, though a larger cutoff of 14.5 mm is also noted in other research.
Yes, mutations in KIT and PDGFRA genes, as well as germline variants near SLC6A18 and TERT, are linked to higher recurrence risk in GIST.
Yes, plozasiran reduces the risk of recurrent pancreatitis in severe hypertriglyceridemia by 83% based on a post hoc analysis of the PALISADE trial.
Yes, obinutuzumab has shown promise in case reports and small studies for FSGS patients who did not respond to rituximab, but larger trials are needed.
Yes, a phase II trial found chiglitazar significantly reduced liver fat in MASLD patients with high triglycerides and insulin resistance.
No, an R1 vascular margin is not considered acceptable for colorectal liver metastases in minimally invasive surgery due to higher local recurrence rates compared to R0 resection.
Yes, minimally invasive surgical thermal ablation (MITA) improves safety for colorectal liver metastases, with low major complication rates and very low mortality.
R1 vascular margins are not considered safe for colorectal liver metastases, as they are linked to higher local recurrence rates compared to R0 resections.
Research suggests natural herbal plants can target autophagy pathways in Metabolic-Associated Fatty Liver Disease, offering a multi-target approach that may be safer than…
Bibliometric analyses show that research on functional dyspepsia has grown over the last 20 years, with China leading in publication volume and the Mayo Clinic ranking as a top…
One study shows that people with functional dyspepsia have different levels of brain connectivity and specific chemical changes in their gut that match their symptom severity.
Single-nucleus RNA sequencing helps researchers map specific cell types and gene networks that drive fibrosis in the liver and kidneys, revealing how healthy repair fails and how…
OPDIVO QVANTIG is not currently approved for esophageal adenocarcinoma, but the active drug inside it, nivolumab, is proven to help treat this cancer when combined with…
Yes, for esophageal adenocarcinoma, achieving a pathologic complete response after neoadjuvant therapy is strongly linked to better survival, especially in certain subgroups.
For esophageal adenocarcinoma, neoadjuvant chemoradiation does not improve overall resection rates but does increase R0 (margin-negative) resection rates compared to chemotherapy…
Single-cell RNA sequencing helps map specific immune cells and communication networks that drive fibrosis in fatty liver disease, revealing new targets for treatment.
Yes, new immunomodulation strategies for liver fibrosis focus on reprogramming macrophages, targeting specific immune subsets, and using metabolic therapies like GLP-1 analogues…
Research shows that diarrhea in the last few weeks is linked to slower visual reaction times in young children, likely due to nutrient depletion and immune stress.
Diarrheal gut samples show lower bacterial diversity and higher levels of harmful bacteria like E. coli, while healthy samples have more beneficial bacteria like Faecalibacterium.
BRAFV600E mutation testing can help identify hidden cancers in thyroid nodules that look dangerous on ultrasound but test benign on standard cell samples.
Comprehensive geriatric assessment helps older adults with gastrointestinal cancers live longer by identifying frailty and changing treatment plans to avoid complications.
Having Lynch Syndrome greatly increases your risk of colon cancer, but it does not mean you will definitely get it. Regular colonoscopies can lower the chance of dying from the…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.